| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.7886 | 
      | Human Intestinal Absorption | HIA+ | 0.9809 | 
      | Caco-2 Permeability | Caco2+ | 0.6953 | 
      | P-glycoprotein Substrate | Non-substrate | 0.6076 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8771 | 
                                                     | Non-inhibitor | 0.8959 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8614 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.8607 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7770 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9173 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6887 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.5302 | 
      | CYP450 2C9 Inhibitor | Inhibitor | 0.5354 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8354 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.6365 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.6661 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5369 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8670 | 
                                                                    | Non-inhibitor | 0.9607 | 
      | AMES Toxicity | Non AMES toxic | 0.7802 | 
      | Carcinogens | Non-carcinogens | 0.8156 | 
      | Fish Toxicity | High FHMT | 0.9851 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9677 | 
      | Honey Bee Toxicity | High HBT | 0.7131 | 
      | Biodegradation | Not ready biodegradable | 0.8254 | 
      | Acute Oral Toxicity | III | 0.6484 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5765 |